# Edward Donovan

> Edward Donovan is the Chicago-area chief executive of TerSera Therapeutics, whose career has moved from West Point and service as a commissioned U.S. Army officer to corporate law, pharmaceutical operations and the chief executive's office. He also serves as president of the board of Code Platoon, connecting his military background with a nonprofit that prepares veterans and military family members for technology careers.

- **Role:** Chief Executive Officer and board member at TerSera Therapeutics
- **Organizations:** TerSera Therapeutics, Code Platoon, Crealta Pharmaceuticals, Actient Pharmaceuticals, Kirkland & Ellis LLP, United States Army
- **Education:** Bachelor of Science, United States Military Academy at West Point, Juris Doctor, University of Virginia School of Law
- **Known for:** Progressed from TerSera's executive vice president, general counsel and secretary to chief operating officer, president and chief executive officer., Became a partner at Kirkland & Ellis after beginning his professional career as a commissioned U.S. Army officer., Has served as president of Code Platoon's board since January 2018, supporting technology-career pathways for veterans and military family members.

## Career timeline

- **1996-2001** — Served as a commissioned officer in the U.S. Army, attaining the rank of captain.
- **2004-2011** — Worked as a partner in Kirkland & Ellis's Chicago office, specializing in mergers and acquisitions, private equity and corporate law, including pharmaceutical and healthcare transactions.
- **2012-2013** — Served as general counsel and secretary at Actient Pharmaceuticals.
- **2013-2016** — Served as general counsel and secretary at Crealta Pharmaceuticals.
- **2016-2023** — Joined TerSera Therapeutics and progressed from executive vice president, general counsel and secretary to chief operating officer and president.
- **2018-present** — Serves as president of the board of Code Platoon.
- **2024-present** — Serves as chief executive officer and a board member of TerSera Therapeutics.

## Achievements

- Progressed from TerSera's executive vice president, general counsel and secretary to chief operating officer, president and chief executive officer.
- Became a partner at Kirkland & Ellis after beginning his professional career as a commissioned U.S. Army officer.
- Has served as president of Code Platoon's board since January 2018, supporting technology-career pathways for veterans and military family members.
- Was serving as TerSera's CEO when the company acquired MARGENZA in 2024 and completed the divestiture of its Infusion Specialty Therapies business in 2026.

## Latest updates

- **2026-03** — TerSera completed the sale of its Infusion Specialty Therapies business to ESTEVE after announcing the agreement in January; Donovan had said the transaction would sharpen TerSera's focus on oncology and rare disease.
- **2025-05** — After TerSera received 2025 USA Today Top Workplace recognition, Donovan credited trust, employee empowerment and individual contributions.
- **2025-07** — Code Platoon announced an expansion of its mission to adult children of veterans and active-duty service members; Donovan described the change as a step toward broader technology-career opportunity for the military community.
- **2024-11** — TerSera completed its acquisition of MARGENZA from MacroGenics, adding the product to its oncology portfolio.

## Links

- Website: https://tersera.com/bio/edward-donovan
- LinkedIn: https://www.linkedin.com/in/edward-donovan-650004149/

---

Profile page: https://yespress.io/edward-donovan
Published by YesPress — https://yespress.io
Last updated: 2026-09-27